<DOC>
	<DOCNO>NCT00030043</DOCNO>
	<brief_summary>This study gather information safety efficacy penetrate auditory brainstem implant ( PABI ) patient neurofibromatosis type 2 .</brief_summary>
	<brief_title>An Implant Hearing Loss Due Removal Neurofibromatosis 2 Tumors</brief_title>
	<detailed_description>Neurofibromatosis Type 2 ( NF2 ) characterize multiple tumor cranial spinal nerve , , particular , bilateral acoustic tumor . Surgical resection tumor generally result transection VIIIth nerve , destruction cochlea auditory nerve , total hearing loss . Due loss auditory nerve , patient candidate cochlear implantation . The Auditory Brainstem Implant ( ABI ) provide available intervention restore auditory sensation patient . An ABI implantable prosthesis produce sound sensation electrical stimulation ascend auditory pathway level cochlear nucleus . The PABI may place surgically tumor resection . Efficacy assess use psychophysical standard speech reception measure .</detailed_description>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 2</mesh_term>
	<criteria>Inclusion criterion : Diagnosis neurofibromatosis type 2 Speak English primary language Exclusion criterion : Physical , psychological , medical condition contraindicate surgical procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2002</verification_date>
	<keyword>Electric Stimulation</keyword>
	<keyword>Implants , Artificial</keyword>
	<keyword>Brainstem</keyword>
	<keyword>Electrodes</keyword>
	<keyword>Speech Perception</keyword>
</DOC>